NCT05408702View on ClinicalTrials.gov

Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 12, 2021

Primary Completion Date

May 15, 2022

Study Completion Date

May 15, 2022

Conditions
Autoimmune Myasthenia GravisLambert-Eaton Myasthenic SyndromeCongenital Myasthenic SyndromeMyasthenia Gravis
Trial Locations (1)

Unknown

Online Questionnaire, Paris

All Listed Sponsors
collaborator

Association Française contre les Myopathies (AFM), Paris

OTHER

lead

Institut de Myologie, France

OTHER

NCT05408702 - Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes | Biotech Hunter | Biotech Hunter